(Q40771890)

23 September 2017

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity (English)

1 reference

23 September 2017

1 reference

Dubuquoy L

7

0 references

Johan Auwerx

16

object named as

Auwerx J

1 reference

23 September 2017

Rocchi S

1

1 reference

23 September 2017

Picard F

2

1 reference

23 September 2017

Vamecq J

3

1 reference

23 September 2017

Gelman L

4

1 reference

23 September 2017

Potier N

5

1 reference

23 September 2017

Zeyer D

6

1 reference

23 September 2017

Bac P

8

1 reference

23 September 2017

Champy MF

9

1 reference

23 September 2017

Plunket KD

10

1 reference

23 September 2017

Leesnitzer LM

11

1 reference

23 September 2017

Blanchard SG

12

1 reference

23 September 2017

Desreumaux P

13

1 reference

23 September 2017

Moras D

14

1 reference

23 September 2017

Renaud JP

15

1 reference

23 September 2017

1 October 2001

1 reference

23 September 2017

1 reference

23 September 2017

8

1 reference

23 September 2017

4

1 reference

23 September 2017

737-747

1 reference

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Spontaneous α-N-6-Phosphogluconoylation of a “His Tag” inEscherichia coli:The Cause of Extra Mass of 258 or 178 Da in Fusion Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Studying noncovalent protein complexes by electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Thiazolidinediones: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Peroxisome proliterator-activated receptors, orphans with ligands and functions

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Steroid receptor coactivator-1 is a histone acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Diet-induced type II diabetes in C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2801%2900353-7

7 January 2021

10.1016/S1097-2765(01)00353-7

Identifiers

DOI

1 reference

23 September 2017

1 reference